Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
13.01.2025 13:55:56

EQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

13.01.2025 / 13:55 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: SCHOTT Pharma AG & Co. KGaA
Street: Hattenbergstraße 10
Postal code: 55122
City: Mainz
Germany
Legal Entity Identifier (LEI): 529900TU48UE99NHEY88

2. Reason for notification
X Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: T. Rowe Price Group, Inc.
City of registered office, country: Baltimore, Maryland, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
06 Jan 2025

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 3.01 % 0.02 % 3.03 % 150614616
Previous notification 2.75 % 0.03 % 2.78 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A3ENQ51 0 4531969 0.00 % 3.01 %
Total 4531969 3.01 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
shares on loan 35500 0.02 %
    Total 35500 0.02 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
T. Rowe Price Group, Inc. % % %
T. Rowe Price Associates, Inc. % % %
T. Rowe Price International Ltd 3.01 % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
08 Jan 2025



13.01.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

2066563  13.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2066563&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu SCHOTT Pharma

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
17.02.25 SCHOTT Pharma Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.02.25 SCHOTT Pharma Buy Deutsche Bank AG
13.02.25 SCHOTT Pharma Hold Jefferies & Company Inc.
13.02.25 SCHOTT Pharma Neutral UBS AG
30.01.25 SCHOTT Pharma Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Digital vs Kreditkarten: Wer gewinnt das Zahlungs-Rennen? – Wall Street Live mit Tim Schäfer

In der heutigen Ausgabe von Wall Street Live geht es um Digitale Zahlungssysteme. Warum haben Unternehmen wie Visa, Mastercard und American Express kaum Konkurrenz? Wo liegen die Probleme von PayPal und wird Apple Pay in Zukunft noch mehr im digitalen Zahlungsumfeld mitspielen? Diese und weitere Fragen beantwortet Tim Schäfer in der heutigen Ausgabe von Wall Street Live.

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Digital vs Kreditkarten: Wer gewinnt das Zahlungs-Rennen? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’320.62 19.54 BHDSPU
Short 13’603.43 13.61 UBSOUU
Short 14’102.96 8.89 QIUBSU
SMI-Kurs: 12’804.69 20.02.2025 17:30:00
Long 12’270.79 19.69 B3LSBU
Long 11’989.35 13.76 BSRSOU
Long 11’472.86 8.89 BY2SIU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten